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Background
Several policy and economic challenges come up in the
quest for Aids Vaccine development and trial in Ghana
and Africa as a whole. In resource limited countries like
Ghana, individuals often must wait for several years
before they have access to licensed vaccines. Key policy
issues and economic challenges affecting Aids vaccine
development and trial include; providing adequate fund-
ing for public and private sector research, enforcing pro-
tection for human subjects in clinical trials as well as
speeding regulatory consideration of clinical trials.
Method
This presentation will look at potential policy interven-
tions and each stage of the product development and
delivery process. There will be a review of academic writ-
ings and current policy proposals and well as considering
the merits and limitations of several proposals.
Results
As far as Aids vaccine research is concern, Policy makers
have a critical role to play. A variety of policy interven-
tions are required to achieve accelerated results.
Conclusion
For speedy Aids vaccine research and trials, policy makers
should carefully access the merits of policy proposals and
enact changes as and when it's necessary.
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